CY2027 Medicare Physician Fee Schedule: What Dermatology and Specialty Practices Must Do Before January 1

The comment period on the CY2027 Medicare Physician Fee Schedule closed yesterday. If the proposed Modifier 25 change is finalized, specialty practices that bill same-day E/M visits with procedures will lose up to 50% of the payment on one of those services — effective January 1, 2027.

That's not a theoretical risk. It is a concrete payment rule published in the Federal Register (91 FR 43842, July 16, 2026) that CMS is now preparing to finalize. For dermatology practices performing Mohs surgery with same-day office visits, ENT practices billing FESS with evaluation, and orthopedic practices documenting post-operative encounters alongside injections — the math changes dramatically in 107 days.

And the Modifier 25 cut isn't arriving alone. The conversion factor drops another 1.68% for non-advanced-APM participants. The OBBBA Medicaid state-directed payment phase-down begins its countdown. For specialty practices in high-Medicaid states like Texas, this is a three-front revenue assault.

What the Modifier 25 Change Actually Does

Today, Modifier 25 allows a provider to bill a separate E/M visit on the same day as a procedure when the E/M is for a "significant, separately identifiable" condition. Dermatologists use this routinely: a patient comes in for a suspicious lesion, the physician performs both an evaluation (E/M) and a biopsy (procedure). Both are billed. Both are paid in full.

The CY2027 proposed rule changes this calculation:

Under the proposed rule, when an E/M visit (billed with Modifier 25) and a procedure are performed on the same day, the lower-paying of the two services gets its payment cut by 50%. If the E/M visit happens to be the higher-paying service, the procedure payment is halved instead.

This is not a documentation change. It's not a modifier requirement adjustment. It's a direct, automatic payment reduction applied at the claim level.

Dermatology Is Ground Zero

Dermatology practices are disproportionately exposed because same-day E/M plus procedure is the structural reality of dermatologic care — not an edge case.

• Mohs surgery + E/M — The pre-operative evaluation and the surgery happen in the same visit. Modifier 25 has historically allowed separate billing for both.
• Biopsy + E/M — A patient presents with a skin concern. The physician evaluates, makes a clinical decision, and performs the biopsy. Two distinct services. One visit.
• Ablation + office visit — Actinic keratosis treatment alongside a comprehensive skin exam. Different clinical purposes. Same day.
• Excision + E/M — Lesion removal following a diagnostic evaluation that established the surgical indication.

These scenarios represent 20–35% of a typical dermatology practice's billing volume. For a mid-size practice billing $2–4 million annually, the Modifier 25 change alone could reduce revenue by $200,000 to $700,000 per year.

The American Academy of Dermatology has pushed back aggressively in the comment period. But practices cannot afford to plan around a reversal that may not come.

ENT and Orthopedics Face the Same Math

The exposure extends well beyond dermatology:

The American Association of Orthopaedic Surgeons issued a pointed warning, stating the proposed changes would cause "irreparable damage by instituting acute cuts to orthopedic care that will change the face of American healthcare indefinitely."

That language signals a lobbying battle. It does not signal a guarantee of reversal. The CMS finalization window is open, and practices need to prepare for both outcomes.

The Conversion Factor Compounds the Problem

The Modifier 25 change arrives alongside the ongoing conversion factor erosion:

• –1.19% for advanced APM participants
• –1.68% for non-advanced-APM participants (the majority of specialty practices)

Without Congressional intervention, these cuts are automatic. Congress has intervened in prior years with temporary patches, but specialty practices that budget around a legislative rescue are budgeting around hope.

The conversion factor drop applies to every Medicare service, not just same-day E/M + procedure claims. Combined with Modifier 25, a dermatology practice could see Medicare revenue decline 5–12% across the board — depending on payer mix and procedure volume.

OBBBA Medicaid Phase-Down: The Third Front

The One Big Beautiful Bill Act imposes new caps on Medicaid state-directed payments (SDPs). These supplemental payments — which currently allow states to boost Medicaid reimbursement up to average commercial rates — now face hard limits:

• 110% of Medicare in non-expansion states
• 100% of Medicare in expansion states

Thirty-seven states currently exceed these limits. The excess is staggering:

For Texas-based practices — BAM AI's core market — the state faces $3.5 billion in excess SDP spending that must be phased down starting in 2028 at 10 percentage points per year. California ($7.4B), Illinois ($4.0B), and Kentucky ($3.9B) face even steeper reductions.

The phase-down doesn't start until 2028, but practices building 2027 budgets need to model the compounding effect: Modifier 25 cuts in January 2027, conversion factor erosion in 2027, and Medicaid SDP phase-down beginning 12 months later.

G2211 Won't Save Procedural Specialties

CMS is also restructuring G2211, the longitudinal care add-on code. In 2027, G2211 shifts from a flat add-on payment to 16% of the E/M service value (32% for qualifying ACO participants).

This is genuinely beneficial — for primary care. For practices managing chronic conditions with ongoing patient relationships, G2211 represents meaningful revenue uplift.

For procedural specialists? Minimal impact. Most dermatology, ENT, and orthopedic practices don't bill G2211 in significant volume because the code requires documented longitudinal care relationships that don't map to episodic surgical encounters. G2211 is the carrot for primary care; Modifier 25 is the stick for procedural specialties.

Budget Neutrality Means Specialty Cuts Fund Primary Care Gains

This is the structural reality CMS doesn't publicize in plain language: the physician fee schedule is budget-neutral. Every payment increase to one specialty must be offset by a payment decrease to another.

The CY2027 proposed rule shifts resources toward:

• Behavioral health — SBIRT codes up ~20%, Collaborative Care Model codes up 20–40%
• Primary care — G2211 expansion, MSSP prospective per-member-per-month payments
• ACO participants — 32% G2211 for qualifying ACO REACH practices

Those gains are funded by cuts to procedural and high-resource specialties. CMS is also eliminating the Indirect Practice Cost Index (IPCI) over two years, which hits radiology, anesthesiology, and high-overhead specialties hardest.

Specialty practices aren't losing revenue to waste elimination. They're losing revenue to budget-neutral redistribution toward primary care and behavioral health. Understanding that distinction matters for strategic planning.

What AI Billing Automation Does Differently

The practices that will navigate 2027 with minimal revenue disruption are the ones adapting their billing infrastructure now — not in December. AI billing automation addresses the Modifier 25 change at three layers:

1. Real-Time Modifier 25 Eligibility Checking

Before a claim is submitted, AI validates whether the same-day E/M + procedure combination meets payer-specific documentation requirements for separately identifiable services. If the documentation doesn't support a separately identifiable E/M, the system flags it before submission — preventing both the 50% reduction and potential audit exposure.

2. E/M Documentation Completeness Verification

The Modifier 25 defense — the reason CMS should pay both services in full — is that the E/M is separately identifiable. That requires distinct HPI, ROS, exam elements, and medical decision-making documentation that stands on its own, independent of the procedure indication. AI verifies that every Modifier 25 claim includes documentation meeting this standard before submission.

3. PFS Conversion Factor Modeling

AI models the revenue impact of the new conversion factor across your entire fee schedule — by payer, by CPT code, by provider. Instead of discovering the impact after your January remittances arrive, you see the projected impact now and can adjust patient volume, payer negotiations, and service mix proactively.

4. Payer-Mix Revenue Risk Analysis

For practices in Texas and other high-Medicaid states, AI quantifies the combined revenue risk from Medicare Modifier 25 cuts, conversion factor drops, and projected OBBBA Medicaid phase-downs. This analysis identifies which service lines face the steepest compounding cuts and where payer-mix optimization can offset losses.

5. Automated Compliance Workflow Adaptation

When CMS publishes the final rule — expected in late November or early December — AI billing systems update compliance rules, modifier logic, and payment expectations automatically. No manual staff retraining. No six-week lag while billing teams learn new rules. Day-one compliance on January 1.

The 107-Day Window: What to Do Now

The comment period is closed. The rule is in CMS's finalization pipeline. Here's what specialty practices should do in the 107 days before potential implementation:

1. Audit your Modifier 25 exposure — Pull every same-day E/M + procedure claim from the last 12 months. Calculate the revenue at risk if either service is reduced 50%. This is your baseline impact number.
2. Stress-test your documentation — For every Modifier 25 claim, verify that the E/M documentation stands independently as a separately identifiable service. If it doesn't, the 50% cut is the least of your problems — those claims are already audit-vulnerable.
3. Model the conversion factor drop — Apply the –1.68% reduction to your entire Medicare fee schedule. Combine it with the Modifier 25 impact. This is your realistic 2027 Medicare revenue projection.
4. Assess your Medicaid SDP exposure — If you're in Texas, California, Illinois, or another high-SDP state, model the 2028 phase-down impact now. Two years of compounding cuts require two years of preparation.
5. Deploy AI billing automation — BAM AI can run a Modifier 25 billing exposure audit on your practice's claims data and model the full revenue impact before January 1.